Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-21

Study Completion Date

2025-09-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL will be randomly assigned to receive either Qualia Magnesium+ or a placebo. Participants will take 2 capsules daily in the evening, with or without food, for a duration of 12 weeks. The primary outcome is the between-group change in RBC magnesium levels from baseline to Week 12. Secondary outcomes include assessments of sleep quality, perceived stress, magnesium status, and safety and tolerability. Data collection will occur through lab bloodwork and electronic questionnaires.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure

NCT05690464

Blood Pressure

ACTIVE_NOT_RECRUITING NA

Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels

NCT06505967

NAD+ Levels in the Blood

RECRUITING NA

Effectiveness of Food-grown Magnesium on Sleep Quality/Quantity

NCT05825209

Sleep

COMPLETED PHASE3

Bioavailability of Magnesium Supplements

NCT03353636

Healthy Magnesium Deficiency

COMPLETED NA

Effectiveness of Qualia NAD+ Supplementation on NAD Levels

NCT06812416

Intracellular NAD+ Levels

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Magnesium Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qualia Magnesium+®

Qualia Magnesium+® Supplement

Group Type ACTIVE_COMPARATOR

Qualia Magnesium+®

Intervention Type DIETARY_SUPPLEMENT

Qualia Magnesium+® manufactured by Qualia Life Sciences

Placebo

Rice Flour

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Rice Flour

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qualia Magnesium+®

Qualia Magnesium+® manufactured by Qualia Life Sciences

Intervention Type DIETARY_SUPPLEMENT

Placebo

Rice Flour

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide voluntary, written, informed consent to participate in the study
* Agree to provide a valid cell phone number and are willing to receive communications through text
* Can read and write English
* Willing to complete questionnaires, records, and diaries associated with the study.
* Male and female participants aged 21 years and older
* Willing and able to visit a local blood draw facility for required blood sample collections
* Live within 20 miles of a suitable blood draw facility (such as Quest)
* RBC Magnesium levels below 6.0 mg/dL
* Willing to not consume any supplements containing magnesium starting about 2 weeks prior to the baseline magnesium blood test and continuing through the intervention period.
* Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly with the exception of those containing magnesium

Exclusion Criteria

* Women who are pregnant, breastfeeding, or planning to become pregnant during the trial
* Known food intolerances/allergy to any ingredients in the product
* Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
* Having had a significant cardiovascular event in the past 6 months
* Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
* On immunosuppressive therapy
* Individuals who were deemed incompatible with the test protocol
* Adults lacking capacity to consent

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes